Creig S. Hoyt, MD, MA is Emeritus Professor and Chair of the Department of Ophthalmology at the University of California San Francisco. Dr. Hoyt is a co-author of the highly regarded Pediatric Ophthalmology and Strabismus, 4th Edition.
Dr. Hoyt is a graduate of Cornell University Medical Center. He completed his residencies in neurology and ophthalmology at the University of California, San Francisco, and performed his fellowship at Royal Children’s Hospital, Melbourne, Australia. Dr. Hoyt is board certified in ophthalmology, and his special areas of expertise include esotropia; lazy eye strabismus; Leber`s amaurosis, neuro-ophthalmology, ophthalmic genetics, and pediatric ophthalmology.
Brad Bowling, MB ChB, FRCSEd(Ophth), FRCOphth, FRANZCO, grew up in northern England, graduating in medicine from Liverpool University in 1990. He trained in ophthalmology in Liverpool, Cardiff and Oxford, accolades including the Muthusamy Gold Medal for the highest score in the Final Fellowship examination of the Royal College of Surgeons of Edinburgh. He went on to work as a consultant at teaching hospitals in Buckinghamshire and Blackpool, achieving UK NHS Clinical Excellence Awards in 2008, 2009 and 2011. Posts held include South Buckinghamshire Clinical Lead in Ophthalmology, Chair of the Oxford Deanery Ophthalmology Professional Development Group and Director of the Buckinghamshire Postgraduate Ophthalmology Teaching Programme. Dr. Bowling is an author of research papers in major international journals, including the largest study to date of optometric glaucoma referrals.
Dr. Bowling has co-authored several ophthalmology textbooks, including the seventh edition of Clinical Ophthalmology – A Systematic Approach, which under the original author Dr. Jack Kanski has been an international standard for nearly thirty years, and Synopsis of Clinical Ophthalmology, 3rd Edition. The medical student book Ophthalmology – An Illustrated Colour Text won the prestigious Richard Asher Award of the Society of Authors, and is a recommended text in many medical schools worldwide; it is included in the WHO Standard List for a Vision 2020 Eye Care Service Unit. Dr. Bowling is also an author of Ophthalmology in Focus.
Related Authors: Jack Kanski, MD
Stephen J. Ryan, MD is President of the Doheny Eye Institute and Grace and Emery Beardsley Chair of Ophthalmology. He has also served Dean of the Keck School of Medicine and Senior Vice President for Medical Care of the University of Southern California. An internationally recognized expert in the field of retinal diseases and ocular trauma, he has authored over 250 scientific publications and has delivered over 20 named or memorial lectures. He is author of the text Retina, 5th Edition.
Dr. Ryan is a member of numerous ophthalmologic organizations and has served in leadership roles in several. He has also served as a Member of the NIH National Advisory Eye Council and as a Member of the Visual Sciences “A” Study Section in the Division of Research Grants at the National Institutes of Health. Dr. Ryan’s numerous awards include the Louis B. Mayer Scholar Award from Research to Prevent Blindness, Inc., The Johns Hopkins University Society of Scholars, the American Academy of Ophthalmology’s Senior Honor Award, and the Fight for Sight/Mildred Weisenfeld Lifetime Research Achievement Award.
“Being an editor on a journal and seeing the latest research, I get to see what’s happening in translational research that will soon be available to the clinician. It’s fun and exciting to see the research employed and then to put it in a more definitive form in a textbook.” – Dr. Daniel Albert
My co-editor, Dr. Leonard Levin, and I worked together on the Archives of Ophthalmology Journal, put out by the American Medical Association, which had a section called “Mechanisms of Disease.” We realized that there was a need and a tremendous interest in not just knowing how to treat diseases by memorizing the medicines or the operation, but in how to correlate the basic pathophysiology and biochemistry defects with managing the disease. That became our most recent work, Ocular Disease: Mechanisms and Management.
New areas in the field are the tremendous clinical trials and epidemiological studies that are going on now to find best practices. There’s a big movement now for something called “less is more” where we’re starting to realize that a number of diseases are over-treated. This is not only a waste of resources but there are detrimental effects from over-treatment. Being an editor on a journal and seeing the latest research, I get to see what’s happening in translational research that will soon be available to the clinician. It’s fun and exciting to see the research employed and then to put it in a more definitive form in a textbook.
Intellectually, Ocular Disease: Mechanisms and Management and Adler’s Physiology of the Eye just fit together. Adler’s Physiology of the Eye is a special book because Dr. Adler was one of the people that got me interested in ophthalmology. I read each edition of his book. It’s a very scientific and incisive look at how the eye should function. To me, it was almost crying out for a counterpart about what goes wrong and how it can be fixed. So, taking our cue from Adler’s Physiology, we created a counterpart for the diseased eye.
Bio
Daniel M. Albert, MD, MS is the Founding Director of the UW McPherson Eye Research Institute and F.A. Davis Professor in the Department of Ophthalmology and Visual Sciences at the University of Wisconsin Medical School. He is an editor of Ocular Disease: Mechanisms and Management and the third edition of Principles & Practice of Ophthalmology. He is also an editor of Veterinary Ocular Pathology.
Dr. Albert’s research focuses on ocular tumors. For nearly 20 years, he worked with the National Eye Institute’s Collaborative Ocular Melanoma Study and served as the head of the COMS Pathology Center. He continues to curate the specimens collected during the study. Dr. Albert holds a medical degree from the University of Pennsylvania School of Medicine.
Related Authors: Leonard Levin, MD, PHD
“I felt the need to work with something small, clean, and in an area that had a bright future for research. Ophthalmology seemed to be the natural fit.” – Dr. Arun Singh
I was born in England, but I grew up in India, where I went to medical school. I felt the need to work with something small, clean, and in an area that had a bright future for research. Ophthalmology seemed to be the natural fit for that. I studied ophthalmology in New Delhi and then in UK becoming fellow of the Royal College of Ophthalmologists. My last position in England was at St. Bart’s Hospital, where I was exposed to oncology. Since then, I’ve wanted to work in ophthalmic oncology. In 1990, I travelled to U.S. for additional training in Ophthalmic Oncology. Since 2003, I am the Director of Department of Ophthalmic Oncology at the Cole Eye Institute, Cleveland Clinic.
Over the last nine years at the Cleveland Clinic, with my co-editor Brandy Hayden, an expert ultrasonographer, we have developed a vast experience with eye tumors and other retinal diseases that frequently are assessed by ultrasonography. We wanted to share our experience by compiling a book that is easy to read and comprehend. The result is our new book with DVDs, Ophthalmic Ultrasonography, which explains how to do and interpret ophthalmic ultrasonography.
Like in other fields, all ultrasound images are digital, making them easy to access. The resolution is higher and the screens are bigger, so we can see greater details. There are also higher resolution scans for the interneuro segment and ultra-high resolution for the cornea. All of these recent developments are highlighted in the book.
Biography
Arun D. Singh, MD is the director of the Department of Ophthalmic Oncology in the Cole Eye Institute at Cleveland Clinic. He is well-published researcher with more than 250 articles in peer reviewed journals. He is the editor of British Journal of Ophthalmology. He is also a manuscript reviewer for 14 national and international journals, including the Archives of Ophthalmology, Ophthalmology, American Journal of Ophthalmology, and Acta Ophthalmology. He is editor of Ophthalmic Ultrasonography and Clinical Ophthalmic Oncology.
Dr. Singh has specialty interests in ophthalmic tumors in adults and children, with research interests in uveal melanoma, the genetics of retinoblastoma, retinal capillary hemangioma and von Hippel-Lindau disease. He is a member of the American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology American, International Society for Genetic Eye Diseases, International Retinoblastoma Society, Macula Society, Vitreous Society, Royal College of Ophthalmologists and the Jules Gonin Club. Dr. Singh is also Secretary of International Society of Ocular Oncology.
Myron Yanoff, MD is Professor and Chair Emeritus of the Department of Ophthalmology at Drexel University in Philadelphia and adjunct professor of Ophthalmology at the University of Pennsylvania School of Medicine and Temple University. He is a co-author of Ocular Pathology, 8th Edition.
Dr. Yanoff received his medical degree from the University of Pennsylvania Medical School in Philadelphia. He completed residency training in both pathology and ophthalmology at the Hospital of the University of Pennsylvania, followed by a fellowship in ophthalmic pathology at the Armed Forces Institute of Pathology in Washington, D.C. He also performed a retinal fellowship at Wills Eye Hospital in Philadelphia.
Dr. Yanoff was formerly chairman of the Department of Ophthalmology of the University of Pennsylvania and director of the Scheie Eye Institute in Philadelphia. Board-certified in both ophthalmology and pathology, he has published over 190 scientific articles and authored, co-authored, or edited over 45 textbooks in the field of ophthalmology and ocular pathology.
Highly regarded both in the U.S. and worldwide, Dr. Yanoff is a member of numerous associations and societies, including Association for Research in Vision and Ophthalmology, the Verhoeff-Zimmerman Society, the Eastern Ophthalmic Pathology Society, the American Ophthalmological Society, and the Pennsylvania Medical Society, and is a fellow of the College of Physicians of Philadelphia, the American Academy of Ophthalmology, and the American College of Surgeons. Dr. Yanoff is also a charter member of the American Association of Ophthalmic Pathology. Among his awards and recognitions are the Pfizer Visiting Professorship Award and Ophthalmology Times “100 Best Ophthalmologists in America.” In 1988, he received one of the highest honors in American science—the Senior Distinguished U.S. Scientist Award (Humboldt Research Award).
“Ophthalmology provides clinicians with information about new studies: what they show, what they mean, and how can they be applied in practice.” – Jay S. Duker, MD
I was always interested in science as a child. I thought I was going to be a physicist until I realized that physics was all about numbers and math and I was more interested in people. In college I became interested in becoming a doctor. I did laboratory research with John Dowling who was studying the retina in animals, which got me excited about the visual systems and visual pathways. Then, I happened to go to medical school in Philadelphia at Jefferson Medical College, which is affiliated with the Wills Eye Hospital — one of the top programs for ophthalmology in the world. I was lucky that my interests could flourish with my affiliation with Wills.
Ophthalmology has been a team effort from the start. I feel lucky to work with Dr. Myron Yanoff. When I became interested in ophthalmology as a medical student, I took a rotation at Wills in ocular pathology. I was so interested in the topic that the first textbook in ophthalmology I bought was Myron Yanoff’s pathology text, which I read cover-to-cover several times. Being an associate of his and working with him to further ophthalmic knowledge has been tremendous. He’s a wonderful guy and a consummate teacher, and I feel lucky to be able to be in this situation.
We wrote the book to give clinicians information that will help them in their everyday practice. We want them to read something and immediately put it into practice. Having thousands of references or learning a lot about research that may never pan out doesn’t really help clinicians. What does help is practical knowledge to make their patients better. We’ve strived to stress clinically useful information in this book.
What doesn’t change in medicine is that the patients come first and that medical decisions are still based on outcomes analysis. What is changing is that there is much more of an emphasis on outcomes analysis worldwide. Ophthalmology provides clinicians with information about new studies: what they show, what they mean, and how can they be applied in practice. Technology is going to continue to change ophthalmology rapidly in the future. Personalized medicine — the ability to do genetic studies and have other bio markers for disease, and then tailor treatments to individual patients based on genetic susceptibility — is going to be extremely important in the near future. Surgical techniques continue to improve as the technology improves. Imaging techniques are also rapidly changing, both for the front of the eye and the back of the eye. When we first did this book, optical coherence tomography didn’t exist, and now we couldn’t practice modern ophthalmology without it.
Jay S. Duker, MD is an internationally recognized vitreoretinal surgeon, and serves as professor and chair of Ophthalmology at Tufts University School of Medicine and director of the New England Eye Center. He is co-author of the third edition of Ophthalmology.
Dr. Duker specializes in medical and surgical diseases of the posterior segment, and he best known for his contributions to the field of optical coherence tomography (OCT) to diagnose and manage retinal diseases. He has directed several clinical trials at the New England Eye Center. Dr. Duker completed his medical studies at the Jefferson Medical College of Thomas Jefferson University, followed by a fellowship in Vitreoretinal Diseases and Surgery and Intraocular Tumors at Wills Eye Hospital.
Related Author: Myron Yanoff, MD
“Being able to see well is a wonderful thing — for mothers to be able to watch their children grow, for fathers to see their sons outdo them in sports. For anybody to be able to see is a lovely and mysterious thing.” – Dr. George Spaeth
When I was growing up, I watched my father practice as a very busy ophthalmologist, but I had no interest in going into medicine or into ophthalmology. I loved playing the piano and writing poetry and music. My interests were much more in the arts than in medicine. When I went to college, I didn’t really know what I was going to do, but I took pre-med courses anyway. When I finished college, I thought, “Well, I’m not a Mozart and I’m not a Bach. The world doesn’t really need another second-rate composer and I don’t think I’ll make a living as a poet.” So I decided to become a doctor because I would be able to help some people that way.
During my residency, I saw a little girl who didn’t look like a normal child. We found that she had homocystinuria, which had not been diagnosed or even discovered yet. We had discovered this new disease and found that you could treat it with a vitamin B6 effectively. That experience hooked me. I thought, “There are lots of questions out there that need to be answered. It’s nice to help people by trying to answer the unanswered questions about their health.” Being able to see well is a wonderful thing — for mothers to be able to watch their children grow, for fathers to see their sons outdo them in sports. For anybody to be able to see is a lovely and mysterious thing.
There are lots of books out there on ophthalmic surgery. Some are comprehensive. Some are focused, and cover topics like complications of retinal detachment surgery or complications of glaucoma surgery. Ophthalmic Surgery: Principles and Practice, 4th Edition is comprehensive. It covers everything that clinicians need to know, but none of the things they don’t need to know. And, it does it in a way that is articulate and clear so that the reader can feel comfortable knowing they are getting the essential information that will help them do better surgery. I think we probably do that better than any other book.
This book is very personal in many ways. My father was an ophthalmologist, and wrote what was the first major textbook of ophthalmic surgery. As I was moving along in my career, I thought, “Maybe it’s my time to write a book on surgery.” The focus of the book is on the surgical procedures that competent ophthalmologists need to know how to do. The goal is to describe the procedures sufficiently well so that the surgeons can potentially learn just from the book. Of course, now, you have to have a mentor, but in many places of the world, mentors aren’t easy to come by, so we wanted the book to be adequately comprehensive and very specific.
Recognized around the world as a foremost authority on glaucoma, George L. Spaeth, MD is the Louis J. Esposito Research Professor at Wills Eye Institute in Philadelphia. A Fellow of the American College of Surgeons, Dr. Spaeth has received countless awards and honors, including the Lifetime Achievement Award from the American Academy of Ophthalmology. He has authored more than 360 articles in peer reviewed journals, hundreds of commentaries, more than 100 book chapters, 200 editorials, and 18 books. He serves on the editorial boards of six journals. He is the author of the surgical text, Ophthalmic Surgery, 4th Edition, which is used around the world.
Dr. Spaeth’s research activities have centered on the characterization and natural history of the cardinal manifestations of glaucoma: the history, the anterior chamber angle, the visual field and the optic nerve. Fellows trained by Dr. Spaeth currently work in 34 countries on six continents, and include the current or past presidents of the American Glaucoma Society, the European Glaucoma Society, the Chinese Glaucoma Society, the Pan-Arab-African Glaucoma Society, and the Christian Medical College in Lahore, India. Dr. Spaeth was founding member and the first President of the American Glaucoma Society. He was the founder and is current president of the Glaucoma Service Foundation to Prevent Blindness and served as the chair of the Ethics Committee of the American Academy of Ophthalmology.
Leonard A. Levin, MD, PhD is a neuro-ophthalmologist at the University of Wisconsin Medical School, where his clinical work concerns diseases of the optic nerve. He was educated and trained at Harvard, where he also received a PhD in neurobiology. Dr. Levin is active in research on the mechanisms of retinal ganglion cell death, which he studies at the molecular, tissue culture, and whole animal level. He primarily focuses on the role axonal damage plays in inducing loss of retinal ganglion cells, an area common to both neuro-ophthalmology and glaucoma.
Dr. Levin is a well-published author of many articles and books whose works include Adler’s Physiology of the Eye, 11th Edition and Ocular Disease: Mechanisms and Management.
Related Authors: Daniel M. Albert, MD, MS
Jack J. Kanski, MD, MS, FRCS, FRCOphth is one of the most respected authors in the field of ophthalmology. He is Honorary Consultant and Ophthalmic Surgeon of the Prince Charles Eye Unit at King Edward VII Hospital in the United Kingdom. Dr. Kanski is the author of the sixth edition of the medical book, Clinical Ophthalmology: A Systematic Approach. The textbook received first place in the ophthalmology category at the 2008 BMA Medical Book Competition. He is also author of Synopsis of Clinical Ophthalmology, 3rd Edition and Signs in Ophthalmology: Causes and Differential Diagnosis, among others.
Related Author: Brad Bowling, FRCSEd(Ophth), FRCOphth
